Concepts in the pathogenesis of rabies

Future Virology

Volumn 3, Issue 5, 2008, Pages 481-490

  Dietzschold, Bernhard ^a   Li, Jianwei ^a   Faber, Milosz ^a   Schnell, Matthias ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Antiviral immunity; Apoptosis; Pathogenicity determinant; Rabies virus; Virus replication; Virus spread; Virus uptake

Indexed keywords

HOST CELL FACTOR C1; INACTIVATED VACCINE; LIVE VACCINE; RABIES VACCINE; RECOMBINANT VACCINE; THROMBOSPONDIN; VIRUS RNA;

ADAPTIVE IMMUNITY; APOPTOSIS; HOST RANGE; HUMAN; IMMUNOGENICITY; INNATE IMMUNITY; NEUROTROPISM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABIES; RABIES VIRUS; REVIEW; RNA SYNTHESIS; SINGLE DRUG DOSE; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS EXPRESSION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE;

RABIES VIRUS; RHABDOVIRIDAE; RNA VIRUSES;

EID: 55949100542     PISSN: 17460794     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460794.3.5.481     Document Type: Review

References (74)

1. Dietzschold B, Wang HH, Rupprecht CE et al.: Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein. Proc. Natl Acad. Sci. USA 84, 9165-9169 (1987).
2. Tollis M, Dietzschold B, Volta CB, Koprowski H: Immunization of monkeys with rabies ribonucleoprotein (RNP) confers protective immunity against rabies. Vaccine 9, 134-136 (1991).
3. Crandell RA: Arctic fox rabies. In: The Natural History of Rabies. Baer GM (Ed.). CRC Press. Boca Raton, FL, USA (1991).
4. Anderson LJ, Williams LP Jr, Layde JB, Dixon FR, Winkler WG: Nosocomial rabies: investigation of contacts of human rabies cases associated with a corneal transplant. Am. J. Public Health 74, 370-372 (1984).
5. CDC: Rabies in laboratory worker - Texas. Morb. Mortal. Wkly Rep. 1113-1124 (1972).
6. CDC: Rabies in laboratory worker - New York. Morb. Mortal. Wkly Rep. 183-184 (1977).
7. Constantine DG: Rabies transmission by nonbite route. Public Health Rep. 77, 287-289 (1962).
8. Charlton KM, Casey GA: Experimental rabies in skunks: immunofluorescence light and electron microscopic studies. Lab. Invest. 41, 36-44 (1979).
9. Murphy FA, Bauer SF: Early street rabies virus infection in striated muscle and later progression to the central nervous system. Intervirology 3, 256-268 (1974).
10. Shankar V, Dietzschold B, Koprowski H: Direct entry of rabies virus into the central nervous system without prior local replication. J. Virol. 65, 2736-2738 (1991).
11. Klingen Y, Conzelmann KK, Finke S: Double-labeled rabies virus: live tracking of enveloped virus transport. J. Virol. 82, 237-245 (2008).
12. Tsiang H: Evidence for an intraaxonal transport of fixed and street rabies virus. J. Neuropathol. Exp. Neurol. 38, 286-299 (1979).
13. Murphy FA: Rabies pathogenesis. Arch. Virol. 54, 279-297 (1977).
14. Charlton KM, Casey GA, Campbell JB: Experimental rabies in skunks: mechanisms of infection of the salivary glands. Can. J. Comp. Med. 47, 363-369 (1983).
15. Jackson AC, Rossiter JP: Apoptosis plays an important role in experimental rabies virus infection. J. Virol. 71, 5603-5607 (1997).
16. Yan X, Prosniak M, Curtis MT et al.: Silver-haired bat rabies virus variant does not induce apaptosis in the brain of experimentally infected mice. J. Neurovirol. 7, 518-527 (2001).
17. Fu ZF, Weihe E, Zheng YM et al.: Differential effects of rabies and borna disease viruses on immediate-early- and late-response gene expression in brain tissues. J. Virol. 67, 6674-6681 (1993).
18. Tsiang H: Neuronal function impairment in rabies-infected rat brain. J. Gen. Virol. 61(Pt 2), 277-281 (1982).
19. Ceccaldi PE, Fillion MP, Ermine A. Tsiang H, Fillion G: Rabies virus selectively alters 5-HT1 receptor subtypes in rat brain. Eur. J. Pharmacol. 245, 129-138 (1993).
20. Bouzamondo E, Ladogana A, Tsiang H: Alteration of potassium-evoked 5-HT release from virus-infected rat cortical synaptosomes. Neuroreport 4, 555-558 (1993).
21. Iwata M, Komori S, Unno T, Minamoto N, Ohashi H: Modification of membrane currents in mouse neuroblastoma cells following infection with rabies virus. Br. J. Pharmacol. 126, 1691-1698 (1999).
22. Hattwig MAW, Gregg, MB: The disease in man. In: The Natural History of Rabies (Volume II). Baer GM (Ed.). Academic Press, NY, USA, 281-304 (1975).
23. Hooper DC, Morimoto K, Bette M, Weihe E, Koprowski H, Dietzschold B: Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J. Virol. 72, 3711-3719 (1998).
24. Dietzschold B, Faber M, Schnell MJ: New approaches to the prevention and eradication of rabies. Expert Rev. Vaccines 2, 399-406 (2003).
25. Wiktor TJ., Doherty PC, Koprowski H: Suppression of cell-mediated immunity by street rabies virus. J. Exp. Med. 145, 1617-1622 (1977).
26. Lafon M: Subversive neuroinvasive strategy of rabies virus. Arch. Virol. Suppl. 18, 149-159 (2004).
27. Dietzschold B, Schnell M, Koprowski H: Pathogenesis of rabies. Curr. Top. Microbiol. Immunol. 292, 45-56 (2005).
28. Lentz TL, Burrage TG, Smith AL, Crick J, Tignor GH: Is the acetylcholine receptor a rabies virus receptor? Science 215, 182-184 (1982).
29. Thoulouze MI, Lafage M, Schachner M, Hartmann U, Cramer H, Lafon M: The neural cell adhesion molecule is a receptor for rabies virus. J. Virol. 72, 7181-7190 (1998).
30. Tuffereau C, Benejean J, Blondel D, Kieffer B, Flamand A: Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus. EMBO J. 17, 7250-7259 (1998).
31. Tuffereau C, Schmidt K, Langevin C, Lafay F, Dechant G, Koltzenburg M: The rabies virus glycoprotein receptor p75NTR is not essential for rabies virus infection. J. Virol. 81, 13622-13630 (2007).
32. Marsh M, Helenius A: Virus entry into animal cells. Adv. Virus Res. 36, 107-151 (1989).
33. Lewis P, Lentz TL: Rabies virus entry into cultured rat hippocampal neurons. J. Neorocytol. 27, 559-573 (1998).
34. Gaudin Y, Tuffereau C, Segretain D, Knossow M, Flamand A: Reversible conformational changes and fusion activity of rabies virus glycoprotein. J. Virol. 65, 4853-4859 (1991).
35. Dietzschold B, Wunner WH, Wiktor TJ et al.: Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc. Natl Acad. Sci. USA 80, 70-74 (1983).
36. Faber M, Faber ML, Papaneri A et al.: A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity. J. Virol. 79, 14141-14148 (2005).
37. Faber M, Pulmanausahakul R, Nagao K et al.: Identification of viral genomic elements responsible for rabies virus neuroinvasiveness. Proc. Natl Acad. Sci. USA 101, 16328-16332 (2004).
38. Schnell MJ, Mebatsion T, Conzelmann KK: Infectious rabies viruses from cloned cDNA. EMBO J. 13, 4195-4203 (1994).
39. Dietzschold B, Wiktor TJ, Trojanowski JQ et al.: Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro. J. Virol. 56, 12-18 (1985).
40. Morimoto K, Ni YJ, Kawai A: Syncytium formation is induced in the murine neuroblastoma cell cultures which produce pathogenic type G proteins of the rabies virus. Virology 189, 203-216 (1992).
41. Coulon P, Derbin C, Kucera P, Lafay F, Prehaud C, Flamand A: Invasion of the peripheral nervous systems of adult mice by the CVS strain of rabies virus and its avirulent derivative AvO1. J. Virol. 63, 3550-3554 (1989).
42. Kucera P, Dolivo M, Coulon P, Flamand A: Pathways of the early propagation of virulent and avirulent rabies strains from the eye to the brain. J. Virol. 55, 158-162 (1985).
43. Fredericksen BL, Whitt MA: Vesicular stomatitis virus glycoprotein mutations that affect membrane fusion activity and abolish virus infectivity. J. Virol. 69, 1435-1443 (1995).
44. Tang Y, Rampin O, Giuliano F, Ugolini G: Spinal and brain circuits to matoneurons of the bulbospongiosus muscle: retrograde transneuronal tracing with rabies virus. J. Comp. Neurol. 414, 167-192 (1999).
45. Kelly RM, Strick PL: Rabies as a transneuronal tracer of circuits in the central nervous system. J. Neurosci. Methods 103, 63-71 (2000).
46. Mazarakis ND, Azzouz M, Rohll JB et al.: Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum. Mol. Genet. 10, 2109-2121 (2001).
47. Etessami R, Conzelmann KK, Fadai-Ghotbi B, Natelson B, Tsiang H, Ceccaldi PE: Spread and pathogenic characteristics of a G-deficient rabies virus recombinant: an in vitro and in vivo study. J. Gen. Virol. 81, 2147-2153 (2000).
48. Pulmanausahakul R, Li J, Schnell MJ, Dietzschold B: The glycoprotein and the matrix protein of rabies virus affect pathogenicity by regulating viral replication and facilitating cell-to-cell spread. J. Virol. 82, 2330-2338 (2008).
49. Mebatsion T, Weiland F, Conzelmann KK: Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G. J. Virol. 73, 242-250 (1999).
50. Jacob Y, Badrane H, Ceccaldi PE, Tordo N: Cytoplasmic dynein LC8 interacts with lyssavirus phosphoprotein. J. Virol. 74, 10217-10222 (2000).
51. Raux H, Flamand A, Blondel D: Interaction of the rabies virus P protein with the LC8 dynein light chain. J. Virol. 74, 10212-10216 (2000).
52. Tan GS, Preuss MA, Williams JC, Schnell MJ: The dynein light chain 8 binding motif of rabies virus phosphoprotein promotes efficient viral transcription. Proc. Natl Acad. Sci. USA 104, 7229-7234 (2007).
53. Finke S, Conzelmann KK: Dissociation of rabies virus matrix protein functions in regulation of viral RNA synthesis and virus assembly. J. Virol. 77, 12074-12082 (2003).
54. Faber M, Faber ML, Li J, Preuss MA, Schnell MJ, Dietzschold B: Dominance of a nonpathogenic glycoprotein gene over a pathogenic glycoprotein gene in rabies virus. J. Virol. 81, 7041-7047 (2007).
55. Otsuka M, Jing Q, Georgel P et al.: Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Immunity 27, 123-134 (2007).
56. Jopling CL, Norman KL, Sarnow P: Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122. Cold Spring Harb. Symnp. Quant. Biol. 71, 369-376 (2006).
57. Randall C, Panis M, Cooper JD et al.: Cellular cofactors affecting hepatitis C virus infection and replication. Proc. Natl Acad. Sci. USA 104, 12884-12889 (2007).
58. Morimoto K, Hooper DC, Spitsin S, Koprowski H, Dietzschold B: Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. J. Virol. 73, 510-518 (1999).
59. Faber M, Pulmanausahakul R, Hodawadekar SS et al.: Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response. J. Virol. 76, 3374-3381 (2002).
60. Uller L, Andersson M, Greiff L, Persson CG, Erjefalt JS: Occurrence of apoptosis, secondary necrosis, and cytolysis in eosinophilic nasal polyps. Am. J. Respir. Crit. Care Med. 170, 742-747 (2004).
61. Ting JP, Willingham SB, Bergstralh DT: NLRs at the intersection of cell death and immunity. Nat. Rev. Immunol. 8, 372-379 (2008).
62. Kono H, Rock KL: How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8, 279-289 (2008).
63. Dietzschold B, Morimoto K, Hooper DC, Smith JS, Rupprecht CE, Koprowski H: Genotypic and phenotypic diversity of rabies virus variants involved in human rabies: implications for postexposure prophylaxis. J. Hum. Virol. 3, 50-57 (2000).
64. Li J, McGettigan JP, Faber M, Schnell MJ, Dietzschold B: Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NF-κB signaling pathway. Vaccine 26, 419-426 (2008).
65. Faber M, Bette M, Preuss MA et al.: Overexpression of tumor necrosis factor-α by a recombinant rabies virus attenuates replication in neurons and prevents lethal infection in mice. J. Virol. 79, 15405-15416 (2005).
66. Randall RE, Goodbourn S: Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89, 1-47 (2008).
67. Banchereau J, Briere F, Caux C et al.: Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811 (2000).
68. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 392, 245-252 (1998).
69. Becker Y: Immunological and regulatory functions of uninfected and virus infected immature and mature subtypes of dendritic cells - a review. Virus Genes 26, 119-130 (2003).
70. Brzozka K, Finke S, Conzelmann KK: Identification of the rabies virus α/β interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J. Virol. 79, 7673-7681 (2005).
71. Brzozka K, Finke S, Conzelmann KK: Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2. J. Virol. 80, 2675-2683 (2006).
72. Vidy A, Chelbi-Alix M, Blondel D: Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways. J. Virol. 79, 14411-14420 (2005).
73. Blondel D, Regad T, Poisson N et al.: Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies. Oncogene 21, 7957-7970 (2002).
74. Hornung V, Ellegast J, Kim S et al.: 5′-triphosphate RNA is the ligand for RIG-I. Science 314, 994-997 (2006).